Back to Trades
Clark Kenneth A
DirectorCIK 0001561736
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Clark Kenneth A, Director, has filed 1 SEC report (2026), all concentrated in Summit Therapeutics Inc. (SMMT), totaling $925.0K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.